Search Results - "Tural, C"

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults by Rockstroh, JK, Bhagani, S, Benhamou, Y, Bruno, R, Mauss, S, Peters, L, Puoti, M, Soriano, V, Tural, C

“…Objectives With the decline in HIV‐associated morbidity and mortality following the introduction of highly active antiretroviral therapy (HAART), liver disease…”
Get full text

The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis by Murray, M, Hogg, RS, Lima, VD, May, MT, Moore, DM, Abgrall, S, Bruyand, M, D'Arminio Monforte, A, Tural, C, Gill, MJ, Harris, RJ, Reiss, P, Justice, A, Kirk, O, Saag, M, Smith, CJ, Weber, R, Rockstroh, J, Khaykin, P, Sterne, JAC

“…Background We examined whether determinants of disease progression and causes of death differ between injecting drug users (IDUs) and non‐IDUs who initiate…”
Get full text

Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline by Sanmartín, R, Tor, J, Sanvisens, A, López, JJ, Jou, A, Muga, R, Ojanguren, I, Barluenga, E, Videla, S, Planas, R, Clotet, B, Tural, C

“…Objectives The aim of the study was to assess the progression of liver fibrosis in HIV/hepatitis C virus (HCV)‐coinfected patients with no or mild‐to‐moderate…”
Get full text

Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients by Nevot, M., Boesecke, C., Parera, M., Andrés, C., Franco, S., Revollo, B., Ingiliz, P., Tural, C., Clotet, B., Rockstroh, J. K., Martinez, M. A.

“…Summary The growing number of cases of acute hepatitis C (AHC) infections among human immunodeficiency virus type 1 (HIV‐1)‐positive men who have sex with men…”
Get full text

Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort by Manzardo, C., Esteve, A., Ortega, N., Podzamczer, D., Murillas, J., Segura, F., Force, L., Tural, C., Vilaró, J., Masabeu, A., Garcia, I., Guadarrama, M., Ferrer, E., Riera, M., Navarro, G., Clotet, B., Gatell, J.M., Casabona, J., Miró, J.M.

“…In this prospective, multicentre cohort study, we analysed specific prognostic factors and the impact of timing of highly active antiretroviral therapy (HAART)…”
Get full text

Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients by Berenguer, J., González-García, J., López-Aldeguer, J., Von-Wichmann, M. A., Quereda, C., Hernando, A., Sanz, J., Tural, C., Ortega, E., Mallolas, J., Santos, I., Miralles, P., Montes, M. L., Bellón, J. M., Esteban, H.

“…Objectives The two currently available types of pegylated interferon (peg-IFN) used to treat hepatitis C have different pharmacokinetic properties. It is…”
Get full text

P1157 IMPACT OF BASELINE VARIABLES ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH HIV/HCV GENOTYPE-1 COINFECTION IN A PHASE III TRIAL by Tural, C, Rockstroh, J.K, Nelson, M, Bhagani, S, Ingiliz, P, Soriano, V, Núñez, M, Valantin, M.-A, Valdez Madruga, J, Rauch, A, Furtado, J, Battegay, M, Stern, J.O, Quinson, A.-M, Böcher, W, Vinisko, R, Manero, M, Dieterich, D

Get full text

P1122 COMPARISONS OF POPULATIONS IN FALDAPREVIR PHASE III STUDIES BASED ON PEGYLATED INTERFERON a-2a AND RIBAVIRIN-PREDICTED RESPONSIVENESS AND IMPACT ON ACHIEVING SVR12 by Ferenci, P, Jensen, D.M, Dieterich, D, Jacobson, I.M, Romero-Gómez, M, Foster, G.R, Asselah, T, Cooper, C, Tural, C, Streinu-Cercel, A, Ryder, S, Puoti, M, Tam, E, Calleja, J.L, Núñez, M, Quinson, A.-M, Böcher, W, Voss, F, Scherer, J

Get full text

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients by Pineda, J. A., González, J., Ortega, E., Tural, C., Macías, J., Griffa, L., Burgos, A.

“…Transient elastometry (TE) could provide a more accurate evaluation of the frequency and risk factors of liver fibrosis in hepatitis C virus (HCV) infection…”
Get full text

660 HIV/HCV-COINFECTED PATIENTS WHO ACHIEVED SVR ARE STILL AT RISK OF DEVELOPING HEPATOCELLULAR CARCINOMA by Merchante, N, Merino, E, Tural, C, Rivero-Juárez, A, Jover, F, Galindo, M.J, Mínguez, C, Ríos-Villegas, M.J, Márquez-Solero, M, Pineda, J.A

Get full text

474 ADVANCED FIBROSIS AND THE RISK OF LIVER DECOMPENSATION AMONG HIV/HCV-COINFECTED INDIVIDUALS: CONSEQUENCES FOR THE TIMING OF THERAPY AGAINST HCV by Macias, J, Camacho, A, von Wichmann, M.A, López-Cortés, L.F, Ortega, E, Tural, C, Ríos, M.J, Merino, D, Téllez, F, Márquez, M, Pineda, J.A

Get full text

20 PERFORMANCE OF LIVER STIFFNESS COMPARED WITH LIVER BIOPSY TO PREDICT SURVIVAL AND DECOMPENSATIONS OF CIRRHOSIS AMONG HIV/HCV-COINFECTED PATIENTS by Macias, J, Camacho, A, von Wichmann, M.A, López-Cortés, L.F, Ortega, E, Tural, C, Ríos, M.J, Merino, D, T'ellez, F, Márquez, M, Pineda, J.A

Get full text

O35 PREDICTING SURVIVAL OF HIV-INFECTED PATIENTS WITH LIVER CANCER – THE SHILCA SCORE AND STAGING MODEL by Merchante, N, Mínguez, B, Tural, C, Kikuchi, L, Rodríguez-Arrondo, F, Chen, T.-Y, Ventura, M, Harris, M, Daruich, J, Kaplan, D.E, Merino, E, Silva, M.F, Rockstroh, J, Muñoz, J, Jover, F, Klinker, H, Delgado-Fernández, M, Marcus, S, Aberg, J, Pineda, J.A, Sherman, M, Hoshida, Y, Marrero, J, Bräu, N

Get full text

Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users by Sanvisens, A, Fuster, D, Serra, I, Tor, J, Tural, C, Rey-Joly, C, Muga, R

“…Progression of liver fibrosis is associated with the risk of cirrhosis and end-stage liver disease. We aimed to evaluate fibrosis of the liver using three…”
Get more information

Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV‐infected men by Darwich, L, Cañadas, MP, Videla, S, Coll, J, Piñol, M, Cobarsi, P, Molina‐López, RA, Vela, S, García‐Cuyás, F, Llatjos, M, Sirera, G, Clotet, B, Fernández, I., Castella, E., LLatjós, M., Bonjoch, A., Echevarría, P., Jabaloyas, M., Jou, A., Llibre, J. M., Moltó, J., Negredo, E., Pérez‐Alvarez, N., Rey‐Joly, C., Romeu, J., Santos, J. R., Tural, C., Alcalde, C., Guerola, R., Salas, A., Castilla, I., Cirigliano, V., Ejarque, M., López, E., Ordóñez, E., Rueda, L.

“…Background Genital infections with low‐risk (LR) and high‐risk (HR) human papillomavirus (HPV) genotypes are associated with ano‐genital condylomata and anal…”
Get full text

Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors by Franco, S., Bellido, R., Aparicio, E., Cañete, N., García-Retortillo, M., Solà, R., Tural, C., Clotet, B., Paredes, R., Martínez, M. A.

“…Minority drug‐resistant hepatitis C virus (HCV) variants may go undetected yet be clinically important. NS3/4A protease resistance substitutions V36A and…”
Get full text

Long-Lasting Remission of Cytomegalovirus Retinitis without Maintenance Therapy in Human Immunodeficiency Virus-Infected Patients by Tural, C., Romeu, J., Sirera, G., Andreu, D., Conejero, M., Ruiz, S., Jou, A., Bonjoch, A., Ruiz, L., Arnó, A., Clotet, B.

“…Seven AIDS patients who were receiving suppressive therapy for previously diagnosed cytomegalovirus (CMV) retinitis were offered treatment with protease…”
Get full text

Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients by Tural, C., Fuster, D., Tor, J., Ojanguren, I., Sirera, G., Ballesteros, À., Lasanta, J. A. J., Planas, R., Rey-Joly, C., Clotet, B.

“…To assess the factors associated with liver fibrosis in human immunodeficiency virus and hepatitis C virus (HIV/HCV) co‐infected patients eligible for anti‐HCV…”
Get full text

Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection by Moreno, S., García-Samaniego, J., Moreno, A., Ortega, E., Pineda, J. A., Del Romero, J., Tural, C., Von Wichmann, M. A., Berenguer, J., Castro, Á., Espacio, R.

“…The measurement of fibrosis stage critically affects the identification of the progression of liver disease, the establishment of a prognosis and therapeutic…”
Get full text

HIV-1 infected patients older than 50 years. PISCIS cohort study by Navarro, G, Nogueras, M.M, Segura, F, Casabona, J, Miro, J.M, Murillas, J, Tural, C, Ferrer, E, Jaén, A, Force, L, Vilaró, J, García, I, Masabeu, A, Altés, J, Esteve, A, Sued, O, Riera, M, Clotet, B, Podzamczer, D, Gatell, J.M

“…Summary Objective The aim of this study is to characterize the ways in which older HIV-infected people differ from younger HIV-infected people. Methods…”
Get full text